Product Code: CMI4342
Transplantation is a complex area of medicine because when organs or tissues are transplanted from one person to another, the recipient's immune system can reject and destroy the donor organ or tissue and medication would be needed to suppress this immune response.
Organ transplantation is the surgical operation carried out for replacement of damaged organ of an individual. Donated organs are obtained from living donor, deceased donor or from an animal. Whereas in some cases, an artificial organ is used for the transplantation procedure.
Market Dynamics
The global tissue and organ transplantation market is expected to witness significant growth during the forecast period, owing to the technological advancements in transplantation procedures. For instance, in May 2016, Immucor, Inc., a global leader in transfusion and transplantation diagnostics, launched kidney Solid Organ Response Test, kSORT. It is a molecular gene expression assay that measures a kidney recipient's immune response to predict organ rejection and graft injury.
Key features of the study:
- This report provides in-depth analysis of the global tissue and organ transplantation market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global tissue and organ transplantation market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include CryoLife, Inc., Folio Biosciences, Arthrex, AbbVie, Inc., Zimmer Biomet, Medtronic PLC, Novartis AG, Stryker Corporation, Biolife Solutions, Inc. , Teva Pharmaceuticals, and Veloxis Pharmaceutical
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, government initiatives, technological up gradation, market expansion, and marketing tactics
- The global tissue and organ transplantation market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers in the tissue and organ transplantation market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Tissue and Organ Transplantation Market, By Product Type:
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
Global Tissue and Organ Transplantation Market, By Application:
- Organ Transplantation
- Tissue Transplantation
- Global Tissue and Organ Transplantation Market, By End User:
- Hospital
- Transplant Centers
- Others
- Global Tissue and Organ Transplantation Market, By Region:
- North America
- U.S.
- Canada
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Organ Transplantation
- Tissue Transplantation
- Hospital
- Transplant Centers
- Others
- Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Organ Transplantation
- Tissue Transplantation
- Hospital
- Transplant Centers
- Others
- Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Organ Transplantation
- Tissue Transplantation
- Hospital
- Transplant Centers
- Others
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Organ Transplantation
- Tissue Transplantation
- Hospital
- Transplant Centers
- Others
- Middle East
- GCC
- Israel
- Rest of Middle East
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Organ Transplantation
- Tissue Transplantation
- Hospital
- Transplant Centers
- Others
- Africa
- South Africa
- Central Africa
- North Africa
- Tissue Products
- Preservation Solution
- Immunosuppressive Drugs
- Organ Transplantation
- Tissue Transplantation
- Hospital
- Transplant Centers
- Others
- Company Profiles
- CryoLife, Inc.*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Folio Biosciences
- Arthrex
- Abbvie, Inc.
- Zimmer Biomet
- Medtronic PLC
- Novartis AG
- Stryker Corporation
- BiolifeSolutions, Inc.
- Teva Pharmaceuticals
- Veloxis Pharmaceutical
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Regulatory Scenario
- Impact Analysis
- PEST Analysis
- Porter's Analysis
- Advancements in Technological Innovations
- Market Trends
- Growth in Transplant Tourism
- Key Developments
4. Global Tissue and Organ Transplantation Market - Impact of Coronavirus (Covid-19) Pandemic
- Supply side Analysis
- Demand Side Analysis
- Impact on Healthcare Industry
5. Global Tissue and Organ Transplantation Market, By Product Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Tissue Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Preservation Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Immunosuppressive Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Tissue and Organ Transplantation Market, By Application, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Organ transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Tissue transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
7. Global Tissue and Organ Transplantation Market, By End User, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Transplant Centers
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Tissue and Organ Transplantation Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Application, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC
- Israel
- Rest of Middle East
9. Competitive Landscape
- Company Profiles
- CryoLife, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Folio Biosciences
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Arthrex
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbvie, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Zimmer Biomet
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Medtronic PLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Stryker Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- BiolifeSolutions, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Veloxis Pharmaceutical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact